Curcumin upregulates insulin‐like growth factor binding protein‐5 (IGFBP‐5) and C/EBPα during oral cancer suppression

Curcumin is a common food ingredient derived from the plant Curcuma longa and is a potent drug against tumorigenesis. Both insulin‐like growth factor binding protein‐5 (IGFBP‐5) and CCAAT/enhancer‐binding protein α (C/EBPα) are suppressors of head and neck carcinogenesis. We identified curcumin as a...

Full description

Saved in:
Bibliographic Details
Published in:International journal of cancer 2010-07, Vol.127 (1), p.9-20
Main Authors: Chang, Kuo‐Wei, Hung, Pei‐Shih, Lin, I‐Ying, Hou, Chung‐Ping, Chen, Li‐Kai, Tsai, Yin‐Meng, Lin, Shu‐Chun
Format: Article
Language:English
Subjects:
Biological and medical sciences
C/EBPα
carcinoma
curcumin
IGFBP‐5
Medical sciences
Otorhinolaryngology. Stomatology
p38
Tumors
Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Curcumin is a common food ingredient derived from the plant Curcuma longa and is a potent drug against tumorigenesis. Both insulin‐like growth factor binding protein‐5 (IGFBP‐5) and CCAAT/enhancer‐binding protein α (C/EBPα) are suppressors of head and neck carcinogenesis. We identified curcumin as an inducer of IGFBP‐5 expression in multiple types of oral keratinocytes; furthermore, curcumin induces IGFBP‐5 promoter activity in SAS oral cancer cells. Promoter deletion mapping identified a region (nt −71 to nt −59 relative to the transcription start site) as containing a C/EBPα‐binding element that is indispensable for curcumin‐mediated IGFBP‐5 upregulation. Chromatin immunoprecipitation assays revealed that in vivo binding of C/EBPα to this region was remarkably increased in the presence of curcumin. Curcumin increased nuclear C/EBPα expression and IGFBP‐5 expression through p38 activation and this was abrogated by SB203580 treatment. Furthermore, MKK6 expression activated p38 and C/EBPα, increasing IGFBP‐5 promoter activity and expression. Finally, curcumin‐induced IGFBP‐5 expression is associated with the suppression of xenograft tumorigenesis in mice due to oral cancer cells. We conclude that curcumin activates p38, which, in turn, activates the C/EBPα transactivator by interacting with binding elements in the IGFBP‐5 promoter. The consequential upregulation of C/EBPα and IGFBP‐5 by curcumin is crucial to the suppression of oral carcinogenesis.
ISSN:0020-7136
1097-0215
DOI:10.1002/ijc.25220